Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia	Drug Effect; Immunogenicity; Safety Issues	Active, not recruiting	Phase 3	2024-07-11		NCT06497036

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Geropharm	1
I.M. Sechenov First Moscow State Medical University	33
Pharm-Holding	1

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City Clinical Hospital S.P. Botkin of the Moscow City Health Department	Moscow	Russia	1
Federal State Budgetary Educational Institution Bashkir State Medical University of the Ministry of Health of the Russian Federation	Ufa	Russia	1
Kaluga Regional Clinical Hospital	Kaluga	Russia	2
National Medical Research Center in name of V.A. Almazov " of the Ministry of Health of the Russian Federation	Saint Petersburg	Russia	1
Oncological dispensary No. 2 of the Ministry of Health of the Krasnodar Territory	Sochi	Russia	1
Samara State Medical University" of the Ministry of Health of the Russian Federation	Samara	Russia	1